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enemas for prostate patients prior to RT is well documented. 
The role of rectal preparation for bladder patients is not 
evidenced. This work was prompted by the variability in size 
and position of the bladder and surrounding dose limiting 
structures, namely the rectum, noted following the 
implementation of CBCT for this patient group. The influence 
of rectal status and the presence of gas in the rectum will 
affect the geometric accuracy of RT. Inconsistencies in rectal 
status and size may compromise clinical coverage of the 
target volume and sparing of non-target tissue. A limiting 
factor in viewing the bladder volume is often due to 
reconstruction artefacts on the CBCT relating to moving gas 
pockets in the posterior lying rectum. These motion artefacts 
can compromise the accuracy of automatic registrations and 
make it challenging for RTTs to distinguish between soft 
tissue interfaces of organs.  
Materials and Methods: The CBCT scans for a cohort of 20 
patients (10 patients employed no rectal preparation; a 
subsequent10 patients used a micro-enema preparation for 
both planning CT and each treatment fraction). The 224 
CBCT datasets where retrospectively evaluated according to 
the criteria below.  
Criteria for assessment 
 Cross sectional area of rectum at isocentre for CT 
and each CBCT  
 Log rectal status using an arbitrary scale where 
1=empty, 2=gas, 3=faeces and 4=gas and faeces  
 the presence of gas in the mid-sagittal plane using 
a semi-quantitative scale of1–5; representing no gas 
present, gas occupying 5–25%, 25–50%,50–75% and 
75–100% of the rectum respectively. 
· Bladder volume on planning CT and CBCT (cm3) 
RTTs completed a short, verbal questionnaire with patients 
to assess tolerability of the micro-enema. 
Results: The use of a micro-enema was well tolerated by 
bladder patients. Rectal volume variation (status and CSA) 
was reduced with the use of an enema. 
 
 
Conclusions: The introduction of a micro-enema is a well 
tolerated means of managing and reducing inter-fraction 
variation of rectal volume and the presence of gas that can 
compromise the geometric accuracy of RT. Increased focus 
and attention of patient preparation is valuable, alongside 
technical developments, in delivering RT for patients with 
urinary bladder cancer. 
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Purpose/Objective: Incidence of post-radiation carotid 
stenosis is not well defined and co-factors influencing the 
carotid plaque development are poorly investigated. The aim 
of the study is to define incidence of carotid stenosis in 
patients treated with radiotherapy (RT) and to find factors 
influencing stenosis occurrence. 
Materials and Methods: Patients underwent RT for head and 
neck cancer from 2001 to 2012, were included in this 
prospective, monocentric study. Patient demographics, 
clinical comorbidity, type of cancer, unilateral or bilateral 
irradiation, days of RT treatment and elapsed time from RT 
were collected. All patients were evaluated by carotid duplex 
ultrasound (DUS) between June and December 2013. Intimal 
medial thickness (IMT) was calculated in common carotid 
(CC), bulb (B) and internal carotid artery (IC). Stenosis was 
measured with ECST method and was classified in mild (≥25-
<50%), moderate (≥50-<75%) and severe (≥75-≤100%). Primary 
endpoint was to define incidence of >50%-carotid stenosis in 
radiated carotid arteries. Secondary endpoints were to 
detect predictive factors for increase of IMT and >50%-
stenosis. Mann-Whitney test, Kaplan-Meyer methods and Cox 
regression were used. 
Results: Total number of patients was 73 (male 67%; mean 
age 65 years±12), corresponding to 146 carotid pathways, 
whereof 132 (90.4%) were irradiated. Median dose of RT was 
6600 cGy (range 5000-7000). Median RT fractionation was 220 
(range 200-220). Median length of RT was 30 days (range 25-
35). Median time from RT was 3 years (range 0.8-12.3). In 
irradiated patients, mild, moderate and severe stenosis were 
found in 29 (22%), 10 (7.6%) and 3 (2.3%) cases, respectively, 
without significant differences in terms of median time from 
RT between groups. Irradiated carotids had high frequency of 
stenosis compared to non-irradiated group (p=.05). IMT ≥9mm 
in CC, B and IC were associated with longer length of RT 
(p=.012, p=.026 and p=.007, respectively). At 2, 4 and 6 
years, freedom from ≥50%-stenosis was 98%, 91.7% and 85.6%, 
respectively. At multivariate analysis, smoke resulted a 
predictive factor for ≥50%-stenosis (p=.001; OR=7.9; 
95%CI=2.29-27.54). 
Conclusions: Carotid stenosis after radiotherapy for head and 
neck cancer is a frequent event. Occurrence of stenosis in 
irradiated carotids is higher than in non-radiated. Length of 
RT is directly correlated with IMT in CC, B and CI. Smoke 
increased significantly the risk of stenosis. 
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Purpose/Objective: Prostate cancer patients with localised 
disease have a good prognosis but live with the long-term 
effects of RT (up to 20% gastrointestinal problems, and 30-
45% post-RT sexual dysfunction). However, the true extent is 
undoubtedly underestimated, as adverse events (AE) are 
rarely systematically recorded and often under-reported in 
clinician assessments. RT late-effects fully develop and 
